Myriad Genetics Reports Fiscal Second-Quarter 2019 Financial Results

NEXT STORY
New Lactation Rooms Added to the ABOG Educational Foundation Test Center
PREV STORY
Amicus Therapeutics Announces Positive data in Pompe Disease Phase 1/2 Study for Up to 24 Months at 15th Annual WORLDSymposium™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Raptor Pharmaceutical to Present Data on QUINSAIR™ at European Cystic Fibrosis Conference  

NOVATO, Calif., June 07, 2016 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Helsinn Advanced Synthesis wins across all categories at the 2018 CMO Leadership Awards

Helsinn Advanced Synthesis wins across all categories at the 2018 CMO Leadership Awards For ...

author_avatar
NASDAQ Market News

Cyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical Formulations

BERKELEY HEIGHTS, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ...

author_avatar
NASDAQ Market News